Webinar: How to Get Great Place to Work-Certified™
MENU
Revance

Revance

Updated September 2021.

83%

Employees say this is a great place to work


Company Overview

About The Company

Revance’s aesthetics portfolio of expertly created products and services, including DaxibotulinumtoxinA for Injection, the RHA® Collection of dermal fillers, and the OPUL Relational Commerce platform, deliver a differentiated and exclusive offering for the company’s elite aesthetic partners and their patients. Revance has also partnered with Viatris Inc. to develop a biosimilar to BOTOX®, which will compete in the existing short-acting neuromodulator marketplace. Revance’s therapeutics pipeline is currently focused on muscle movement and pain disorders including evaluating DaxibotulinumtoxinA for Injection in two debilitating conditions, cervical dystonia and upper limb spasticity.

COMPANY SIZE

542 U.S.-based Employees
(Medium)

INDUSTRY

Biotechnology & Pharmaceuticals


Employee Demographics

Tenure

Company Culture at Revance

The employee experience below at Revance, compared to a typical company.

Learn More

83% of employees at Revance say it is a great place to work compared to 59% of employees at a typical U.S.-based company.

  • Revance
  • 83%
  • Typical Company
  • 59%

Source: Great Place to Work® 2019 U.S. National Employee Engagement Study.

90%
When you join the company, you are made to feel welcome.
89%
People here are given a lot of responsibility.
89%
When I look at what we accomplish, I feel a sense of pride.
88%
I'm proud to tell others I work here.
87%
I am able to take time off from work when I think it's necessary.

Why Work at Revance?

See what employees say about what makes Revance a great workplace. These words are drawn from employee comments on the Trust Index™ survey.


Best Workplaces Lists

Great Place to Work® is proud to recognize Revance

Don't See Your Company Listed?

Nominate your company today to join Certification Nation

NOMINATE YOUR COMPANY